We initiate China BlueChemical at BUY, assigning a 9x 2026E PE, deriving a target price of HKD3.06. A fertilizer and chemical materials company controlled by CNOOC Group, the company enjoys natural gas cost advantages, which support stable profitability in urea and methanol operations. We also highlight its attractive dividend levels, with a historical payout ratio of c. 40-50% and 2023/2024 year-end dividend yields at 11.5/6.1%. We project 2025E dividend yield at ~6%. Since 2023, reduced capex has expanded cash-like assets beyond market capitalization. We believe that the company stands to benefit from recovering urea and methanol industry dynamics in China. Growth drivers include: 1) its 1.6mtpa phosphate mine is under construction, which should enhance raw material self-sufficiency for phosphate fertilizers; 2) potential export profit upside from widening international -domestic price spreads for urea and phosphate fertilizers since early 2025.
To benefit from self-sufficiency and growing exports
Global phosphate fertilizer demand has maintained growth in recent years. Coupled with expanding lithium iron phosphate (LFP) production, phosphate rock demand has been increasing. On the supply side, limited capacity additions since 2023—due to slowed capex by overseas leaders, stricter Chinese regulatory oversight on over-mining, and declining high-grade reserves—should sustain tight conditions, in our view. We project annual phosphate rock supply deficits of 2-3mn tonnes during 2025-2026, supporting elevated pricing for at least 1-2 years. We believe the company’s 1.6mtpa phosphate mine (slated for 2H26 commissioning) will enhance self-sufficiency, contributing to its earnings growth. Additionally, tightened Chinese phosphate fertilizer exports since early 2025 has widened domestic-international DAP and MAP price spreads, creating medium/long-term profit upside from export volumes.
Where are we different?
While some investors have concerns over the sustainability of tight phosphate rock supply, we believe structural demand drivers—including inelastic phosphate fertilizer needs and expanding LFP capacity—combined with constrained supply (stricter Chinese mining regulations, declining high-grade reserves, and overseas producers’ output discipline) will prolong supply shortages. The market also appears to undervalue the company’s dividend appeal. With sound asset quality, stable cost-advantaged operations, and the liquidity discount in Hong Kong listings, we note the stock offers attractive dividend value.
Earnings forecasts and valuation
We forecast 2025/2026/2027 attributable net profits at RMB1.21/1.41/1.54bn, representing YoY growth of +13/+17/+9%, with EPS of RMB0.26/0.31/0.33. Based on peer companies’ average 11x 2026E PE (Wind consensus) and accounting for the Hang Seng AH Premium Index at ~119, we assign the company a 9x 2026E PE, deriving our target price of HKD3.06 (HKD:RMB=0.913). We initiate Chine BlueChemical at BUY.
Risks: intensified fertilizer competition; slower project execution than we expect; weaker downstream demand growth than we expect.
我有话说